Intrinsic Value

Gain Therapeutics, Inc. (GANX)

$3.19

-0.20 (-5.90%)

Enterprise Value -3,972.53
Net Debt -10.77
Equity Value -3,961.76
Shares Outstanding 13.01
Equity Value Per Share -304.48



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt